早期帕金森病大型研究者发起试验招募流程回顾
该研究描述了左旋多巴治疗早期帕金森病(LEAP)试验的组织方式,并回顾性分析招募流程。招募历时57个月,比预期长27个月,荷兰估计合格患者中仅6.8%被纳入。转诊数量在中心和地区间差异很大,主研究中心所在地区转诊最多。外部评估提示转诊和非纳入原因差异可能涉及临床均势、患者合格性或研究呈现方面的问题。
要点
- LEAP试验招募历时57个月,比预期长27个月。
- 荷兰估计合格患者中仅6.8%被纳入。
- 转诊数量在中心和地区间差异很大,主研究中心所在地区转诊最多。
核心结论
- 在有限预算下执行大型研究者发起临床试验仍有可能,关键在于尽量减少行政和组织程序。
- 与主研究中心机构联系更紧密的中心往往有更高的转诊率。
- 转诊和非纳入原因的差异可能提示存在与临床均势、患者合格性或研究呈现相关的问题。
研究设计与样本
- 对LEAP试验招募流程的回顾性分析,使用QuinteT招募干预(QRI-Two)进行外部评估。
- 分析转诊、纳入和非纳入的模式,以调查转诊和纳入过程中是否存在瓶颈。
主要发现
- 招募历时57个月,比最初预期长27个月。
- 荷兰估计合格患者中6.8%被纳入。
- 转诊数量在荷兰参与中心和地区间差异很大,主研究中心所在地区转诊最多。
- 排除原因因地区而异,一些地区更多患者已经、想要或不想开始帕金森药物治疗。
局限性
- QRI-Two为回顾性使用。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Organizing and executing a large clinical trial is a complex process, and often recruitment targets are not met. We describe the organization of the Levodopa in the Early Parkinson's disease (LEAP) trial and the results of an external assessment of the recruitment process. METHODS: Several strategies were used to ensure that recruitment for the trial was effective and efficient. We analyzed the patterns in referrals, inclusions, and non-inclusions to investigate whether there were bottlenecks in the referral and inclusion process. For the external assessment of the recruitment process, the QuinteT Recruitment Intervention (QRI-Two) was used retrospectively, focusing on finding possible issues impeding recruitment that are less easily recognized. RESULTS: Recruitment took 57 months, which was 27 months longer than initially expected. 6.8% of the estimated eligible patients in the Netherlands were included. The number of referrals differed widely between participating centers and regions in the Netherlands, with the region of the principal study center having the most referrals. Reasons of exclusion varied across regions, as in some regions more patients already started, wanted to start, or did not want to start with Parkinson medication compared to other regions. DISCUSSION: Executing a large, investigator-initiated clinical trial on a limited budget still remains possible by focusing on minimizing administrative and organizational procedures. Our study suggests that centers with closer institutional ties to a principal study center tend to have a higher referral rate. The review of the LEAP trial recruitment strategies and data using the QRI-Two suggested that the variations in referrals and reasons of non-inclusion could indicate the presence of issues related to clinical equipoise, patient eligibility, or study presentation. Integrating a recruitment intervention could have explored issues with study presentation and equipoise that might have increased recruitment efficiency. TRIAL REGISTRATION: ISRCTN ISRCTN30518857 . The registration was initiated on 02/08/2011 and finalized on 25/08/2011. Recruitment started on 17/08/2011, after the initiation of public registration.
引用
- Verschuur CVM, Donovan JL, de Bie RMA, et al. Review of the recruitment process for a large investigator-initiated trial in early Parkinson's disease. Trials. 2022. PMID: 35164821. doi:10.1186/s13063-022-06052-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。